Robert Licul
Oral and Maxillofacial Pathology · Westbury, NYNPI 1700869765
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.6%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Nobel Biocare USA at 47.9% of the total. Among oral and maxillofacial pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $105.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nobel Biocare USA$1K
- Henry Schein, Inc.$600
- Keystone Dental Inc.$495
- Dentsply Sirona Inc$147
- Biohorizons Implant Systems Inc.$84
- SS White Burs LLC$27
- plus $15 from 1 others
What the payments were for
- Speaking & faculty fees$1,32951%
- Food & beverage$80131%
- Entertainment$49519%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nobel Biocare USA | 10 | $1,256 |
| Henry Schein, Inc. | 3 | $600 |
| Keystone Dental Inc. | 6 | $495 |
| Dentsply Sirona Inc | 2 | $147 |
| Biohorizons Implant Systems Inc. | 2 | $84 |
| SS White Burs LLC | 1 | $27 |
| Zimvie Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOBELACTIVE$1,158
- NOBELPARALLEL$603
How this compares
$2,625 in reported general payments places this provider in the 95th percentile of 33 oral and maxillofacial pathology providers in New York.
See all oral and maxillofacial pathology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 202 | $912 |
| Amoxicillin | 229 | $657 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 150 | $298 |
| Clindamycin Hcl | 55 | $270 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 61 | $207 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial pathology in Westbury
- Pasquale MalpesoNew York$7K
- Stanton GoldsteinBayside$2K
- Dwight HershmanBrooklyn$2K
- Steven D'abundoMerrick$2K
- Robert CarpenterSaratoga Springs$2K
- Hillel AbramovElmhurst$2K
- Howard OchsFlushing$1K
- Michael BoyczukWest Seneca$1K
- Kenneth HirschLevittown$1K
- David BlankNew York$997
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.